ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Fabtech Technologies's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 21.43%.
As of today (2026-06-28), Fabtech Technologies's WACC % is 12.05%. Fabtech Technologies's ROC % is 2.03% (calculated using TTM income statement data).
Fabtech Technologies earns returns that do not match up to its cost of capital. It will destroy value as it grows.
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Fabtech Technologies's WACC % is 12.05%. Fabtech Technologies's ROC % is 2.03% (calculated using TTM income statement data).
Fabtech Technologies earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Operating Income data used here is four times the quarterly (Mar. 2026) data.
The tax rate is limited to between 0% and 100%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabtech Technologies (BOM:544558) has a ROC % of 21.43% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Fabtech Technologies and its competitors.
Is Fabtech Technologies' ROC % too high?
Fabtech Technologies' current ROC % is 21.43%. The Healthcare Providers & Services industry median ROC % is 3.06. Fabtech Technologies' value of 21.43% is 600.3% above this industry median. Overall, Fabtech Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Fabtech Technologies' ROC % compare to VEEV and BTSG?
Fabtech Technologies' ROC % of 21.43% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROC % is 3.06. Fabtech Technologies' value of 21.43% is 600.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Healthcare Providers & Services company?
The median ROC % among Healthcare Providers & Services companies is 3.06, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fabtech Technologies's current ROC % of 21.43% is 600.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Fabtech Technologies and its competitors. For the Healthcare Providers & Services industry, the median ROC % is 3.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fabtech Technologies's current ROC % is 21.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabtech Technologies stock overvalued right now?
Fabtech Technologies (BOM:544558) has a current ROC % of 21.43%. The current ROC % is 21.43% and 600.3% above the Healthcare Providers & Services industry median of 3.06. Fabtech Technologies' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Fabtech Technologies (BOM:544558), the current ROC % is 21.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fabtech Technologies Ltd is engaged in building pharmaceutical, biotech, and healthcare capabilities for a wide range of customers by offering comprehensive start-to-finish turnkey solutions, which include supplying pharmaceutical machinery/equipment, in-house designing and engineering, procurement, installation, validation, and undertaking other activities required in various projects, including standalone equipment supply and installation. The company provides solutions for clean air, manufacturing processes, purified water and pure steam generation and distribution, etc. The majority of its revenue is generated from the trading of pharmaceutical and surgical products. Geographically, the company derives maximum revenue from international markets, and the rest from its business in India.
20GF Score
Get the complete analysis for BOM:544558
ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544558 has been successfully added to your 